Sorilla P.
- Country
- France
- Department
- Service de Dermatologie
Research Overview
- Phase 3 Study on the Safety and Efficacy of Upadacitinib Versus Dupilumab in Pediatric Patients Aged 2-12 with Moderate to Severe Atopic Dermatitis
- Efficacy and Safety of Ruxolitinib Cream in Pediatric Patients with Moderate Atopic Dermatitis: A Phase 3b Randomized, Double-Blind, Vehicle-Controlled Study
Data & Insights
Has run more than one trial at 8 of 88 partner sites.
Specializations
Pediatric Dermatology
The investigator specializes in treating children with moderate to severe atopic dermatitis, focusing on innovative therapeutic approaches for patients aged 2 to 12 years who require systemic treatment.
- Pediatric skin conditions
- Advanced therapeutic management
- Systemic treatment approaches
Their research interests center on evaluating treatment efficacy in pediatric dermatological conditions.
Inflammatory Skin Disorders
Their expertise extends to managing chronic inflammatory skin conditions, with particular emphasis on investigating comparative therapeutic outcomes in pediatric populations.
- Inflammatory disease management
- Treatment response assessment
- Long-term disease control
The investigator focuses on evaluating therapeutic responses in chronic skin conditions affecting children.
Clinical Assessment
Their work involves comprehensive evaluation of treatment efficacy metrics and safety profiles in pediatric dermatology, including specialized assessment tools like EASI and vIGA-AD scoring systems.
- Clinical response evaluation
- Safety monitoring
- Treatment optimization
The investigator specializes in measuring and analyzing therapeutic outcomes in pediatric skin disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.